Biologists Uncover Previously Unknown Structure Hiding Inside Human Cells

Biologists still find surprises after reviewing the cells.

In the twist, the University of Virginia and a new organelle in the National Institutes of Health, Dubbed the hemihism. This small membrane bonding structure serves as a mobile recycling center and can keep the key to the treatment of several genetic diseases. The research was published Nature communication.

“It’s like finding a new recycling center in the cell,” said Biophysics at the University of Virginia, the author SEAM Ebrahim, A. statement. “We think hemifusome helps manage the package of cells and process material, and in this process, this process can contribute to the diseases affecting many systems in the body.”

Scientists have not identified previously structure because it is only because it seems when necessary. However, thanks to Cryo-Electron Tomography – flash-pig cells flash and captured them in 3D and nearby atom researchers were able to watch the Ephemeral structure.

Researchers can help the formation of cell nuts of hemifusomes can help the formation of small bags connecting and connecting materials throughout the cell phone. Many vesikli organells can also help create a research. However, some arguments show that hemifusoms do not participate in the endocyosis, the traditional road covering the foreign material of these cells.

“You can think of vesicles like small delivery machines inside the cell,” said Ebrahim, in the statement. “Hemifusome is similar to the loading of the cargo and loads. This is a step in the process we do not exist.”

Despite the natural nature, the hemifusoms are not uncommon. They look surprisingly in certain parts of the cells near the cell membrane.

Again, scientists are not sure how hemifusoms are formed and then disappear. They also hope to understand what the hemifusomes do when it doesn’t work properly. Problems with the problems of how many genetic disorders of cells loads.

“It’s just the beginning,” said Ebrahim in a statement. “Now because we know that hemifusoms are available, we can begin to ask how they behave in healthy cells and things go wrong. This can lead to new strategies for the treatment of complex genetic diseases.”